Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin delivery

被引:79
作者
Chono, Sumio [1 ]
Fukuchi, Rie [1 ]
Seki, Toshinobu [1 ]
Morimoto, Kazuhiro [1 ]
机构
[1] Hokkaido Pharmaceut Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut, Otaru, Hokkaido 0470264, Japan
关键词
Liposomes; Dipalmitoyl phosphatidylcholine; Pulmonary delivery; Insulin; Lung surfactant components; RAT ALVEOLAR MACROPHAGES; ABSORPTION ENHANCERS; SALMON-CALCITONIN; DRUG-DELIVERY; PARTICLE-SIZE; RELEASE;
D O I
10.1016/j.jconrel.2009.03.019
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The pulmonary insulin delivery characteristics of liposomes were examined. Aerosolized liposomes containing insulin were administered into rat lungs and the enhancing effect on insulin delivery was evaluated by changes of plasma glucose levels. Liposomes with dipalmitoyl phosphatidylcholine (DPPC) enhanced pulmonary insulin delivery in rats, however, liposomes with dilauroyl, dimyristoyl, distearoyl or dioleoyl phosphatidylcholine did not. Liposomes with DPPC also enhanced the in vitro permeation of FITC dextran (Mw 4400, FD-4) through the calu-3 cell monolayer by reducing the transepithelial electrical resistance and did not harm lung tissues in rats. These findings suggest that liposomes with DPPC enhance pulmonary insulin delivery by opening the epithelial cell space in the pulmonary mucosa not mucosal cell damage. Liposomes with DPPC could be useful as a pulmonary delivery system for peptide and protein drugs. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:104 / 109
页数:6
相关论文
共 27 条
[1]   ACCUMULATION OF AMIODARONE AND DESETHYLAMIODARONE BY RAT ALVEOLAR MACROPHAGES IN CELL-CULTURE [J].
ANTONINI, JM ;
REASOR, MJ .
BIOCHEMICAL PHARMACOLOGY, 1991, 42 :S151-S156
[2]   Conductive airway surfactant: Surface-tension function, biochemical composition, and possible alveolar origin [J].
Bernhard, W ;
Haagsman, HP ;
Tschernig, T ;
Poets, CF ;
Postle, AD ;
vanEijk, ME ;
vonderHardt, H .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 17 (01) :41-50
[3]   Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections [J].
Chono, Sumio ;
Tanino, Tomoharu ;
Seki, Toshinobu ;
Morimoto, Kazuhiro .
JOURNAL OF CONTROLLED RELEASE, 2008, 127 (01) :50-58
[4]   Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification [J].
Chono, Sumio ;
Tanino, Tomoharu ;
Seki, Toshinobu ;
Morimoto, Kazuhiro .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 (01) :75-80
[5]   Influence of particle size on drug delivery to rat alveolar macrophages following pulmonary administration of ciprofloxacin incorporated into liposomes [J].
Chono, Sumio ;
Tanino, Tomoharu ;
Seki, Toshinobu ;
Morimoto, Kazuhiro .
JOURNAL OF DRUG TARGETING, 2006, 14 (08) :557-566
[6]   Impact of formulation and methods of pulmonary delivery on absorption of parathyroid hormone (1-34) from rat lungs [J].
Codrons, V ;
Vanderbist, F ;
Ucakar, B ;
Préat, V ;
Vanbever, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (05) :1241-1252
[7]   Absorption enhancers for nasal drug delivery [J].
Davis, SS ;
Illum, L .
CLINICAL PHARMACOKINETICS, 2003, 42 (13) :1107-1128
[8]   Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3 [J].
Florea, BI ;
Cassara, ML ;
Junginger, HE ;
Borchard, G .
JOURNAL OF CONTROLLED RELEASE, 2003, 87 (1-3) :131-138
[9]   Systemic delivery of drugs to humans via inhalation [J].
Gonda, I .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2006, 19 (01) :47-53
[10]  
HAWGOOD S, 1991, LUNG